Searched for
AJIT KAMATH
Zerodha investors booked Rs 50,000 crore profit in 4 years: Nithin KamathIndian markets witnessing an equity boom with investors realizing profits of Rs 50,000 crore over four years and holding unrealized profits...- HCL founder Shiv Nadar most generous person; Premji slips to second position: Hurun India Philanthropy List 2022HCL founder Shiv Nadar on Thursday was named as the most generous person in the country with an annual donation of Rs 1,161 crore, the Edel...
- Bengaluru’s Phoenix Kessaku hosts 2019 Hurun Stars of businessHurun Report also recognised top industry firms with the 'Industry Achievement Awards'.
- Controversy over IIM-C Director’s appointment: Ambuj Mahanti, a former dean and an aspirant, files writ petitionMahanti’s petition says that a preferential clause has been used as an eliminatory clause for rejecting applications, ignoring merits of ot...
- Mitsui & Co buys additional 25% stake in Arch Pharmalabs for Rs 372 croreMitsui is buying out the stakes of IL&FS Trust Co, IDBI Trusteeship Services and Rainbow Fund, according to an application to the FIPB.
- Mid-cap pharma firms focus on LatAm marketLupin and Glenmark Pharmaceuticals are leading Indian mid-cap drug makers in exploiting rising demand for medicines in South American natio...
- Arch Pharmalabs becomes a leading API makerBorn out of an ailing pharma company, Arch Pharmalabs is now a leading API maker.
- Arch Pharma buys Benzochem for Rs 100 crPrivate equity-controlled Arch Pharmalabs has acquired a controlling stake in Benzochem Lifesciences, an active pharmaceutical ingredients ...
- Arch Pharmalabs signs MoU with France-based Texcell SADrug firm Arch Pharmalabs on Thursday said it has signed a memorandum of understanding with France-based Texcell SA for providing immunolog...
- Arch Pharmalabs Ltd changing horizonsThe entrepreneurial bug bit him at a very young age of 22 and the outcome was a financial services company. In 1998 his life changed track,...
- Arch Pharmalabs looking at takeovers in EuropeAfter strengthening its foothold on the home turf, active pharmaceutical ingredient (API) manufacturer Arch Pharmlabs is looking for takeov...
- What 2008 holds?Opportunities and challenges galore? This is what the industries think.
- Arch Pharma to buy out promoters in Hyderabad company AvonArch Pharmalabs, which recently acquired a 43% stake in Hyderabad-based pharma company Avon Organics, will raise its stake to a majority by...
- Arch Pharmalabs in manufacturing tie-up with DSMArch Pharmalabs expects to earn $100 million by 2010 from the bulk drug manufacturing deal it has entered into with chemicals group DSM, an...
- DSM Anti Infectives, Arch in strategic pactGlobal multispeciality chemical company, DSM has entered into a manufacturing agreement with pharma major Arch Pharmalabs for manufacturing...
- Arch Pharmalabs acquires 42 pc of Avon OrganicsMumbai-based Arch Pharmalabs on Sunday said it is acquiring 42 per cent stake in BSE-listed Avon Organics for Rs 20 crore.
- Arch Pharmalabs acquires Watsol OrganicsCrug maker Arch Pharmalabs has acquired Watsol Organics for Rs 30 crore.
- Mudra appoints Ajit Menon to head HR functionThe Mudra Group has chosen to look beyond advertising while getting one of its latest recruits in. Ajit Menon who joins Mudra Group as exec...
- Arch Pharma plans to raise Rs 100 crore private equityArch Pharmalabs, a Rs 246-crore Mumbai-based active pharmaceutical ingredient (API) manufacturer, is close to raising Rs 100 crore through ...
- Arch Pharmalabs to raise Rs 100 cr via pvt placementArch Pharmalabs, a Rs 246-crore Mumbai-based active pharmaceutical ingredient (API) maker, is close to raising Rs 100 crore through private...
Load More
